Register Login
Register to leave comments
  • News bot Oct. 18, 2025, 5:25 p.m.

    🌍 CureVac (CVAC) - Form 6-K Filing

    Filing Date: 2022-06-08

    Accepted: 2022-06-08 16:21:16

    Event Type: Clinical Trial Update

    Event Details:

    CureVac N.V. (Nasdaq CVAC) announced its acquisition of Frame Cancer Therapeutics, a private company focused on advanced genomics and bioinformatics. The addition of Frames technology and talent to CureVacs oncology research complements our ability to identify neoantigens.

    💼 Business Developments:

    • ✅ Partnership/Collaboration
    • ✅ Acquisition Activity
    • ❌ Licensing Agreement: Not reported
    • ✅ Regulatory Milestone
    • ❌ Leadership Updates: Not reported

    📞 Contact Information:

    • Email: sarah.fakih@curevac.com

Search

News categories